Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Request Sectional Data
Thank you!
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Veterinary Assistive Reproduction Technology Market was valued at USD 6.8 billion in 2023 and is set to register growth at 6.8% CAGR from 2024 to 2032. One of the primary drivers is the rising demand for high-value livestock and pets, which has increased the need for advanced assisted reproductive technologies to enhance breeding efficiency and genetic quality.
To get key market trends
Farmers and breeders are increasingly adopting ART methods, such as artificial insemination, in vitro fertilization, and embryo transfer, to optimize reproductive outcomes and improve herd productivity. Additionally, advancements in veterinary science and biotechnology have led to the development of more effective and accessible ART techniques, further propelling market growth.
Another major driver of the Veterinary ART market is the growing awareness and acceptance of these technologies among pet owners and livestock producers. The increased focus on animal health and welfare, coupled with the desire to preserve and propagate valuable genetic traits, has led to a higher adoption rate of assistive reproductive technologies. Furthermore, government initiatives and funding for animal husbandry and agricultural development are supporting the adoption of ART, especially in emerging economies, further propelling the market growth.
Veterinary assistive reproduction technology (ART) encompasses a range of medical procedures used to aid in the reproduction of animals. These technologies are essential in animal breeding, conservation of endangered species, and improving the genetics and health of livestock.
Rising demand for animal breeding is significantly driving the market.
As livestock farming and pet ownership increase, there is a growing need to improve the genetic quality, productivity, and health of animals.
Advanced reproductive technologies such as artificial insemination, embryo transfer, and in vitro fertilization are becoming essential tools for breeders to enhance breeding efficiency, manage genetic diversity, and address food demand issues.
Globally, farmers are expected to produce 70% more food to feed a population that is estimated to reach 9.6 billion by 2050. Most of this growth is expected in developing countries.
Rapid urbanization in developing countries is also responsible for increasing concerns regarding food security. As of 2021, approximately 55% of the global population lived in urban areas, a percentage expected to increase to 73% by 2050.
Due to these population and urbanization trends, the consumption of animal products is expected to increase significantly, driving the demand for advanced animal breeding technologies.
Learn more about the key segments shaping this market
Based on type, the market is segmented into services, instruments, semen, and kit & consumables. The services segment dominated the market in 2023 and accounted for USD 2.9 billion.
The market is experiencing significant growth, with services holding a high market share.
This dominance can be attributed to the increasing demand for specialized reproductive services, which are essential for improving breeding outcomes and genetic diversity in livestock and companion animals.
Additionally, the rising awareness and adoption of advanced reproductive techniques among veterinarians and animal breeders have driven the market's growth.
Moreover, the high cost and complexity of ART procedures often necessitate professional expertise, further boosting the reliance on specialized services.
Learn more about the key segments shaping this market
Based on technology, the veterinary assistive reproduction technology market is segmented into artificial insemination (AI), in vitro fertilization (IVF), embryo transfer (MOET), and other technologies. The artificial insemination (AI)segment dominated the market in 2023 with a market share of 71.5%.
Artificial insemination offers significant advantages in genetic improvement, disease control, and reproduction management across various animal species, making it a preferred choice among veterinarians and breeders.
Its widespread adoption is particularly notable in livestock, where it enhances the efficiency of breeding programs and ensures the dissemination of desirable genetic traits.
Additionally, increasing awareness and acceptance of artificial insemination among pet owners for companion animals contribute to its growing market share.
Based on animal type, the veterinary assistive reproduction technology market is segmented into bovine, swine, ovine, caprine, equine, and other animal types. The bovine segment dominated the market in 2023 and is expected to witness growth at a CAGR of 6.6%.
The high market share is primarily attributed to the substantial demand for dairy and beef products, which necessitates the enhancement of reproductive efficiency and genetic quality in cattle. Advanced reproductive technologies have been extensively adopted to improve herd productivity, enhance breeding programs, and ensure the genetic diversity of bovine populations.
Additionally, rising awareness among farmers and breeders about the benefits of ART in maximizing reproductive outcomes and the increasing investments in veterinary healthcare infrastructure contribute to the prominent position of bovines in this market segment.
This trend is further supported by favorable government initiatives and subsidies aimed at boosting livestock productivity and the continuous advancements in reproductive biotechnologies tailored specifically for bovine species.
Based on end-use, the veterinary assistive reproduction technology market is segmented into veterinary clinics and hospitals, animal breeding centers, research institutes and universities, and other end-users. The veterinary clinics and hospitals segment is anticipated to reach USD 5.1 billion by 2032.
These facilities often have specialized equipment and trained personnel necessary to perform complex ART procedures.
Additionally, these establishments typically maintain close relationships with pet owners and breeders, providing a steady demand for reproductive technologies aimed at enhancing breeding outcomes and addressing fertility challenges in animals.
Looking for region specific data?
North America dominated the global veterinary assistive reproduction technology market in 2023 with a market share of 38.6% and is anticipated to grow at a CAGR of 6.5% between 2024 – 2032.
The region boasts advanced veterinary healthcare infrastructure and a strong focus on animal welfare, driving demand for assistive reproductive technology solutions aimed at improving breeding outcomes and genetic diversity in companion and livestock animals.
Additionally, the presence of leading veterinary research institutions and technology providers in North America facilitates continuous innovation in ART techniques, further bolstering market growth.
U.S. veterinary assistive reproduction technology market is anticipated to grow at a CAGR of 6.4% between 2024 - 2032.
The U.S. holds a significant market share in the veterinary assisted reproduction technology market due to advanced infrastructure, substantial investments in research and development, and a high demand for advanced veterinary healthcare services.
Additionally, high livestock population in the country increases the demand for these services. For instance, there are 28.2 million beef cows in the U.S. as of Jan. 1, 2024.
Germany is anticipated to witness robust growth in the global veterinary assistive reproduction technology market.
The country's strong veterinary healthcare infrastructure, coupled with advanced research and development capabilities in biotechnology and reproductive sciences, supports the adoption of ART solutions among veterinary clinics and animal breeding facilities.
Moreover, increasing pet ownership rates and a growing emphasis on animal welfare further drive demand for ART services.
Asia Pacific region is anticipated to witness high growth in veterinary assistive reproduction technology market, growing at a CAGR of 7.5% over the analysis years.
Increasing awareness and adoption of advanced veterinary healthcare services across countries like China, Japan, India, and Australia are driving demand for assistive reproduction technology procedures in companion animals and livestock.
Additionally, supportive government initiatives aimed at enhancing animal health and productivity in agricultural sectors are encouraging investment in advanced reproductive technologies.
Lastly, collaborations between international veterinary organizations and local entities are facilitating technology transfer and improving access to ART services, further stimulating market growth in the region.
The competitive landscape in the market is characterized by a mix of established players and emerging innovators, each striving to carve out a niche in this rapidly evolving sector. Technological advancements such as in vitro fertilization (IVF), embryo transfer techniques, and genetic screening tools have spurred competition, driving companies to differentiate through efficacy, cost-effectiveness, and the ability to cater to diverse animal species. Moreover, partnerships with veterinary hospitals, research collaborations, and strategic acquisitions are common strategies employed to expand market presence and enhance technological capabilities in this dynamic field.
Prominent players operating in the veterinary assistive reproduction technology industry include:
Bovine Elite, LLC
CRV Holdings B.V.
Geno SA
Genus Plc
Minitube Group
SEMEX
Select Sires, Inc.
Swine Genetics International
STgenetics
URUS Group LP
VikingGenetics
Veterinary Assistive Reproduction Technology Industry News:
In January 2023, BullWise and CRV announced a collaboration, under which BullWise became the leading distributor for CRV genetics in Ireland & Northern Ireland, offering farmers access to CRV's top bulls from New Zealand's grazing breeding program, as well as bulls specifically selected for the Irish market from CRV's breeding programs. The partnership aims to improve the quality and productivity of herds in the region.
In June 2021, Genus Plc’s bovine division-ABS, collaborated with World Wide Sires Deutschland GmbH to operate jointly as World Wide Sires Deutschland in Austria, Luxembourg, and Germany as ABS’ distribution partner. This helped the company strengthen its distribution network.
The veterinary assistive reproduction technology market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 - 2032 for the following segments:
to Buy Section of this Report
Market, By Type
Services
Semen
Normal semen
Sexed semen
Instruments
Kit & consumables
Market, By Technology
Artificial insemination (AI)
In vitro fertilization (IVF)
Embryo transfer (MOET)
Other technologies
Market, By Animal Type
Bovine
Swine
Ovine
Caprine
Equine
Other animal types
Market, By End-use
Veterinary clinics and hospitals
Animal breeding centers
Research institutes and universities
Other end-users
The above information is provided for the following regions and countries:
North America
U.S.
Canada
Europe
Germany
UK
France
Spain
Italy
Netherlands
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East and Africa
South Africa
Saudi Arabia
UAE
Rest of Middle East and Africa
Author: Mariam Faizullabhoy, Gauri Wani
Frequently Asked Question(FAQ) :
Which factors are driving veterinary assistive reproduction technology market growth in North America?+
North America veterinary assistive reproduction technology accounted for 38.6% share in 2023 and is projected to expand at 6.5% CAGR between 2024 and 2032, due to the presence of advanced veterinary healthcare infrastructure and a strong focus on animal welfare.
Why is the demand for AI veterinary assistive reproduction technology rising?+
The artificial insemination technology segment in the veterinary assistive reproduction technology industry accounted for 71.5% share in 2023 as it offers significant advantages in genetic improvement, disease control, and reproduction management across various animal species.
How big is the veterinary assistive reproduction technology market?+
Veterinary assistive reproduction technology industry size was USD 6.8 billion in 2023 and is projected to expand at 6.8% CAGR from 2024 to 2032, due to the rising demand for high-value livestock and pets.
Why is the demand for veterinary assistive reproduction technology services rising?+
The services type segment in the veterinary assistive reproduction technology industry accounted for USD 2.9 billion in 2023 owing to the increasing demand for specialized reproductive services.
